Co-treatment with quercetin and cisplatin synergistically inhibits proliferation, migration, and invasion and enhances apoptosis in HeLa and SiHa human cervical cancer cells by weakening matrix metallopeptidase 2 (MMP2), ezrin, P-glycoprotein, and methyltransferase-like 3 (METTL3) expressions [118]. The gene discussed is METTL3; the disease is cervical cancer.